PagrindinisMEHCQ • OTCMKTS
add
Chrome Holding Co
Ankstesnė uždarymo kaina
3,60 $
Dienos intervalas
3,45 $ - 3,57 $
Metų intervalas
0,47 $ - 6,21 $
Bendroji vertė rinkoje
96,40 mln. USD
Vidutinė prekybos apimtis
125,12 tūkst.
Kainos ir pajamų santykis
-
Pajamos iš dividendų
-
Pagrindinė akcijų birža
OTCMKTS
Aktualios naujienos
Apie
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously confrontational relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Įkurta
bal. 2006
Pagrindinė būstinė
Svetainė
Darbuotojų skaičius
261